Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm

NCT04695015 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT04695015
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04695015 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research of Pathological Imaging Diagnosis of Ocular Tumors Based on New Artificial Intelligence Algorithm
Lead sponsor
Peking University
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2020
Completion date
June 1, 2022
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma, melanoma (skin), melanoma in situ, nevus eye, ocular tumor, sebaceous gland carcinoma of the eyelid, squamous cell carcinoma in situ